Werfen today announced it has received all three 2026 IMV ServiceTrak™ Clinical Laboratory Awards in Coagulation (Hemostasis), earning Best Customer Satisfaction, Best System Performance, and Best Service. Based on independent feedback from laboratory professionals nationwide, the awards recognize manufacturers that deliver outstanding customer satisfaction, system reliability, and service excellence. These awards build on Werfen's leadership in the Coagulation category since its introduction in 2018 and underscore the company’s long-standing commitment to delivering reliable performance, responsive support, and positive customer outcomes.

The IMV ServiceTrak™ 2026 Clinical Laboratory Awards are based on independent research conducted with clinical laboratory professionals across the United States. Results are based on interviews from nearly 2,000 clinical testing locations representing more than 4,000 instruments. For more than 25 years, the ServiceTrak™ program has served as an industry benchmark for customer satisfaction, system performance, and service excellence. 

“We are honored to be recognized by the 2026 IMV Awards, a recognition that reflects the quality of our products and the exceptional service we provide to our customers. This achievement is a testament to the dedication and specialization of our entire team—from the people who design and manufacture our innovative solutions to those who support our customers every day. Together, their commitment enables us to fulfill our purpose of Powering Patient Care.”

Bill Crandell, Vice President of Commercial Operations, North America, at Werfen

“Winning the ServiceTrak™ Best of Customer Satisfaction, Best System Performance and Best Service awards reflects real feedback from the clinical lab professionals who use Werfen’s systems every day. These awards are grounded in independent, data-driven research, which makes them one of the most credible benchmarks in the industry.”

Richa Singh, VP Strategic Insights, at IMV, part of Science and Medicine Group